Alberto Bardelli
机构: University of Torino and IFOM ETS
每年引用次数
引用次数
引用: 76,178
H-指数: 113
I10-指数 : 275
出版物: 567
Abstract LB-299: A comprehensive platform of patient-derived xenografts and matched cell lines mirrors the genomic landscape of colorectal cancer
Alberto Bardelli , Sabrina Arena , Luca Lazzari , Giorgio Corti
Cancer Research 79
2019
Abstract LB-257: Liquid biopsy versus tissue biopsy to assess acquired resistance and tumor heterogeneity in gastrointestinal cancers
David P. Ryan , Colin D. Weekes , Eunice L. Kwak , Jason E. Faris
Cancer Research
2019
Mutational Profile of GNAQQ209 in Human Tumors
Simona Lamba , Lara Felicioni , Fiamma Buttitta , Fonnet E. Bleeker
PLoS ONE 4 ( 8) e6833
63
2009
Acquired resistance to EGFR targeted therapies in colorectal cancer
Beth O. Van Emburgh , Andrea Sartore-Bianchi , Federica Di Nicolantonio , Salvatore Siena
Molecular Oncology 8 ( 6) 1084 -1094
148
2014
Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.
Giulia Siravegna , Alberto Bardelli
Molecular Oncology 10 ( 3) 475 -480
37
2016
Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.
Aparna R. Parikh , Ignaty Leshchiner , Liudmila Elagina , Lipika Goyal
Nature Medicine 25 ( 12) 1949 -1949
2019
The prognostic IDH1 R132 mutation is associated with reduced NADP + -dependent IDH activity in glioblastoma
Fonnet E. Bleeker , Nadia A. Atai , Simona Lamba , Ard Jonker
Acta Neuropathologica 119 ( 4) 487 -494
201
2010
Corrigendum to Preclinical models for precision oncology. BBACAN 1870/2 (2018) 239-246.
Maider Ibarrola-Villava , Andrés Cervantes , Alberto Bardelli
Biochimica et Biophysica Acta 1872 ( 2) 188292
1
2019
Preclinical models for precision oncology.
Maider Ibarrola-Villava , Andrés Cervantes , Alberto Bardelli
Biochimica et Biophysica Acta 1870 ( 2) 239 -246
17
2018
Genomic landscapes of cancers: prospects for targeted therapies
Fonnet E Bleeker , Alberto Bardelli
Pharmacogenomics 8 ( 12) 1629 -1633
9
2007
Oncogenes and angiogenesis: a way to personalize anti-angiogenic therapy?
Alessia Bottos , Alberto Bardelli
Cellular and Molecular Life Sciences 70 ( 21) 4131 -4140
15
2013
Identification of cancer genes by mutational profiling of tumor genomes
Silvia Benvenuti , Sabrina Arena , Alberto Bardelli
FEBS Letters 579 ( 8) 1884 -1890
24
2005
Broccoli, PTEN deletion and prostate cancer: where is the link?
Giovanni Appendino , Alberto Bardelli
Molecular Cancer 9 ( 1) 308 -308
4
2010
Absence of AKT1 mutations in glioblastoma
Fonnet E. Bleeker , Simona Lamba , Carlo Zanon , Angela A. van Tilborg
PLOS ONE 4 ( 5) 1 -3
28
2009
Abstract SY21-03: Cancer evolution as a therapeutic target
Alberto Bardelli
Cancer Research 77
2017
Abstract CT005: Final results of the HERACLES trial in HER2-amplified colorectal cancer
Salvatore Siena , Andrea Sartore-Bianchi , Livio Trusolino , Cosimo Martino
Cancer Research 77
14
2017
Mutational Profiling of Kinases in Human Tumours of Pancreatic Origin Identifies Candidate Cancer Genes in Ductal and Ampulla of Vater Carcinomas
Stefano Barbi , Niccola Funel , Daniela Campani , Alberto Bardelli
PLoS ONE 5 ( 9) e12653 -5
15
2010
Lemur tyrosine kinase 2 (LMTK2) is a determinant of cell sensitivity to apoptosis by regulating the levels of the BCL2 family members.
Annalisa Conti , Maria Teresa Majorini , Enrico Fontanella , Alberto Bardelli
Cancer Letters 389 59 -69
26
2017
Plasma HER2 (ERBB2) copy number to predict response to HER2-targeted therapy in metastatic colorectal cancer.
Alberto Bardelli , Giulia Siravegna , Andrea Sartore-Bianchi , Rebecca J Nagy
Journal of Clinical Oncology 36 3506 -3506
6
2018
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type
Stefano Barbi , Ivana Cataldo , Giovanni De Manzoni , Samantha Bersani
Journal of Experimental & Clinical Cancer Research 29 ( 1) 32 -32
52
2010